Etico Lifesciences Pvt Ltd. announces esteemed partner received an ANDA approval for a topical dosage form aimed at treating acne vulgaris
Etico Lifesciences Pvt Ltd., an integrated research & development organization, is proud to announce that our esteemed partner received an ANDA approval for a topical dosage form aimed at treating acne vulgaris. We are glad to be a part of this complex project.
Etico Lifesciences Pvt Ltd. proudly announces that our esteemed partner received an ANDA approval for a topical dosage form aimed at treating acne vulgaris. We are thrilled to have played a pivotal role as an analytical service provider by conducting the essential Complex Drug Product Analytical Method Validations at our facility. Our heartfelt congratulations and best wishes go out to the entire team whose dedication and hard work contributed to this remarkable success.
At Etico, our commitment to delivering the highest quality services to our clients remains unwavering. This accomplishment stands as a testament to our ongoing efforts in consistently meeting our clients’ needs within stipulated timelines. The approval of this product marks yet another significant milestone for us, underscoring our dedication to excellence in the industry.
